AnitaJKumarMDMSCE

PubMed

• 1 citations
  Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population-Level Analysis of Statewide Claims Data.
  Anem Waheed, Angie Mae Rodday, Anita J Kumar, Kenneth B Miller, Susan K Parsons> ;JCO Clinical Cancer Informatics. 2022 May 1
• 2 citations
  Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
  Terry K. Pak, Brianne N. Dixon, Michael J Buege, Phuong H. Dao, Megan H. Leary, Joy C. Jarrett, Tara A. Duggan, Philip Caron, Lorenzo Falchi, Paul A. Hamlin, Audrey Ha...> ;Leukemia & Lymphoma. 2021 Nov 16
• 9 citations
  Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.
  Caitlin Stewart, Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank, Paul A. Hamlin, Matthew J. Matasar, John F. Gerecitano, Pamela Dr...> ;Clinical Cancer Research. 2021 Oct 6
• 4 citations
  Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.
  Angie Mae Rodday, Theresa Hahn, Anita J. Kumar, Peter K. Lindenauer, Jonathan W. Friedberg, Andrew M. Evens, Susan K. Parsons> ;JAMA Network Open. 2021 Oct 1
• 18 citations
  Cancer-related impairments and functional limitations among long-term cancer survivors: Gaps and opportunities for clinical practice.
  Larissa Nekhlyudov, Grace Campbell, Kathryn H. Schmitz, Gabriel A. Brooks, Anita J. Kumar, Patricia A. Ganz, Diane Von Ah> ;Cancer. 2021 Sep 16
• 2 citations
  Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects.
  Rachel Murphy-Banks, Anita J. Kumar, Nicole Savidge, Emma Livne, Susan K. Parsons, Mingqian Lin> ;Supportive Care in Cancer. 2021 Sep 15
• Perceptions of Role in Treatment Decision Making and Understanding of Late Effects Among Hodgkin Lymphoma Survivors: Results From a National Survey HL Decision Making ...
  Anita J. Kumar, Rachel Murphy-Banks, Ruth Ann Weidner, Susan K. Parsons> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Aug 1
• 5 citations
  Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapy
  Anita Kumar, Jason Nelson, Angie Mae Rodday, Andrew M. Evens, Jonathan W. Friedberg, Tanya M. Wildes, Susan K. Parsons> ;Journal of Geriatric Oncology. 2021 Nov 1
• 26 citations
  Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
  Anita Kumar, Carla Casulo, Ranjana H. Advani, Elizabeth Budde, Paul M. Barr, Connie Lee Batlevi, Philip Caron, Louis S. Constine, S.V. Dandapani, Esther Drill, Pamela ...> ;Journal of Clinical Oncology. 2021 Apr 28
• 2 citations
  Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience.
  Zachary D. Epstein-Peterson, Nivetha Ganesan, Juliet N. Barker, Pamela Drullinsky, Paola Ghione, Ann A. Jakubowski, Anita Kumar, Alison J. Moskowitz, Ariela Noy, Migue...> ;Leukemia & Lymphoma. 2021 Mar 29
• Perspectives on Geriatric Hematology Research presented at the 2020 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology re...
  Maya Abdallah, Cian McEllistrim, Anita J. Kumar, Kah Poh Loh> ;Journal of Geriatric Oncology. 2021 Feb 20
• 6 citations
  Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
  Erel Joffe, Yan Leyfman, Esther Drill, Sridevi Rajeeve, Andrew D. Zelenetz, M. Lia Palomba, Craig H. Moskowitz, Carol S. Portlock, Ariela Noy, Steven M. Horwitz, John ...> ;Blood Advances. 2021 Jan 26
• 30 citations
  Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in The Rituximab-Era
  Sabela Bobillo, Erel Joffe, Jessica A. Lavery, David Sermer, Paola Ghione, Ariela Noy, Philip Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, M...> ;Blood. 2021 Jan 7
• 8 citations
  Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by A...
  Anita Kumar, Kurt S. Bantilan, Allison P. Jacob, A. Park, S.F. Schoninger, Craig S. Sauter, Gary A. Ulaner, Carla Casulo, Malek Faham, K.A. Kong, Ravinder K. Grewal, J...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jan 1
• Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes
  J Tay, S Beattie, C Bredeson, R Brazauskas, N He, I A Ahmed, M Aljurf, M Askar, Y Atsuta, S Badawy, A Barata, A M Beitinjaneh, N S Bhatt, D Buchbinder, J Cerny, S Ciur...> ;Current Oncology. 2020 Dec 1
• 58 citations
  Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.
  David Sermer, Connie L Batlevi, M. Lia Palomba, Gunjan L. Shah, Richard J. Lin, Miguel-Angel Perales, Michael Scordo, Parastoo B. Dahi, Martina Pennisi, Aishat Afuye, ...> ;Blood Advances. 2020 Oct 13
• 18 citations
  Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists
  Kah Poh Loh, Maya Abdallah, Sindhuja Kadambi, Megan Wells, Anita J. Kumar, Jason H. Mendler, Jane L. Liesveld, Marsha N. Wittink, Kristen M. O'Dwyer, Michael W. Becker...> ;Leukemia & Lymphoma. 2021 Jan 28
• 8 citations
  Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
  David Sermer, Sabela Bobillo, Ahmet Dogan, Yanming Zhang, Venkatraman E. Seshan, Jessica A. Lavery, Connie Lee Batlevi, Philip Caron, Audrey Hamilton, Paul A. Hamlin, ...> ;Blood Advances. 2020 Jul 28
• 68 citations
  Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
  Connie Lee Batlevi, Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying, Jacob D. Soumerai, Philip Caron, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Stev...> ;Blood Cancer Journal. 2020 Jul 17
• 53 citations
  Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms.
  Natasha Lewis, Kseniya Petrova-Drus, Sarah Huet, Zachary D. Epstein-Peterson, Qi Gao, Allison E. Sigler, Jeeyeon Baik, Neval Ozkaya, Alison J. Moskowitz, Anita A Kumar...> ;Blood Advances. 2020 May 26
• 21 citations
  [18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients.
  Marius E. Mayerhoefer, Christopher C. Riedl, Anita Kumar, Ahmet Dogan, Peter Gibbs, Michael Weber, Philipp B. Staber, Sandra Huicochea Castellanos, Heiko Schöder> ;Cancers. 2020 May 2
• 1 citations
  Time to diagnostic resolution after an uncertain screening mammogram in an underserved population
  Anita Kumar, Darcy Banco, Elise E. Steinberger, Joanna Chen, RuthAnn Weidner, Shital S. Makim, Susan K. Parsons> ;Cancer Medicine. 2020 May 1
• 10 citations
  Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Tra...
  David Buchbinder, Ruta Brazauskas, Khalid Bo-Subait, Karen K. Ballen, Susan K. Parsons, Tami John, Theresa Hahn, Akshay Sharma, Amir Steinberg, Anita D'Souza, Anita J....> ;Biology of Blood and Marrow Transplantation. 2020 Mar 1
• 8 citations
  First‐line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)‐Medicare population‐based study
  Angie Mae Rodday, Theresa Hahn, Anita Kumar, Peter K. Lindenauer, Jonathan W. Friedberg, Andrew M. Evens, Susan K. Parsons> ;British Journal of Haematology. 2020 Feb 23
• 2 citations
  Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.
  Michael J Buege, Anita Kumar, Brianne N. Dixon, Laura A. Tang, Terry Pak, Jennifer S. Orozco, Tim J Peterson, Kathryn T. Maples> ;The Annals of Pharmacotherapy. 2020 Feb 20
• Join now to see all

Abstracts/Posters

• Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens
  Anita J Kumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• The Development and Validation of an Electronic Health Record (EHR)-Based Algorithm for Identifying Treatment Failure in Newly Diagnosed Hodgkin Lymphoma (HL) Treated ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018